Cargando…

DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma

BACKGROUND: DNA damage response (DDR) proficiency is the principal mechanism of temozolomide (TMZ) resistance in glioma. Accumulating evidence has also suggested the determining role of DDR in anticancer immunity. We propose that a comprehensive investigation of the DDR landscape can optimize glioma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Mu, Huang, Bingsong, Zhu, Lei, Wang, Qi, Pang, Ying, Cheng, Meng, Lian, Hao, Liu, Min, Zhao, Kaijun, Xu, Siyi, Zhang, Jing, Zhong, Chunlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204352/ https://www.ncbi.nlm.nih.gov/pubmed/35720326 http://dx.doi.org/10.3389/fimmu.2022.875648

Ejemplares similares

Flap endonuclease 1 and DNA-PKcs synergistically participate in stabilizing replication fork to encounter replication stress in glioma cells
por: Zhang, Jing, et al.
Publicado: (2022)

RECQ1 Promotes Stress Resistance and DNA Replication Progression Through PARP1 Signaling Pathway in Glioblastoma
por: Zhang, Jing, et al.
Publicado: (2021)

Deciphering the role of QPCTL in glioma progression and cancer immunotherapy
por: Liu, Yu’e, et al.
Publicado: (2023)

DNA Damage Repair in Brain Tumor Immunotherapy
por: Zhao, Shihong, et al.
Publicado: (2022)

Functional characterization of TSPAN7 as a novel indicator for immunotherapy in glioma
por: Chen, Long, et al.
Publicado: (2023)

Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
por: Teng, Chubei, et al.
Publicado: (2022)

Genomic Analysis Uncovers Immune Microenvironment Characteristics and Drug Sensitivity of Ferroptosis in Breast Cancer Brain Metastasis
por: Zhu, Lei, et al.
Publicado: (2022)

DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma
por: Chen, Yunfei, et al.
Publicado: (2021)

Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy
por: Ye, Zu, et al.
Publicado: (2021)

Advances of DNA Damage Repair-Related Drugs and Combination With Immunotherapy in Tumor Treatment
por: Wang, Yumin, et al.
Publicado: (2022)

Immunotherapy: a promising approach for glioma treatment
por: Yasinjan, Feroza, et al.
Publicado: (2023)

Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
por: Zeng, Jiayi, et al.
Publicado: (2021)

Pre-clinical models for evaluating glioma targeted immunotherapies
por: Frederico, Stephen C., et al.
Publicado: (2023)

Immunodiagnosis — the promise of personalized immunotherapy
por: Wang, Renjie, et al.
Publicado: (2023)

Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma
por: Yan, Dongming, et al.
Publicado: (2022)

Prognostic Features of the Tumor Immune Microenvironment in Glioma and Their Clinical Applications: Analysis of Multiple Cohorts
por: Zhang, Chunlong, et al.
Publicado: (2022)

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer
por: Zhao, Zidan, et al.
Publicado: (2023)

Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
por: Chuntova, Pavlina, et al.
Publicado: (2019)

Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
por: Guo, Yugang, et al.
Publicado: (2018)

The Involvement of Long Non-Coding RNAs in Glioma: From Early Detection to Immunotherapy
por: Wu, Xiaoben, et al.
Publicado: (2022)

Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas
por: Han, Mingzhi, et al.
Publicado: (2022)

MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients
por: Zhang, Chunyu, et al.
Publicado: (2022)

Structural and Functional Overview of TEAD4 in Cancer Biology
por: Chen, Mu, et al.
Publicado: (2020)

Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma
por: Zeng, Yu, et al.
Publicado: (2022)

Risk stratification based on DNA damage-repair-related signature reflects the microenvironmental feature, metabolic status and therapeutic response of breast cancer
por: Li, Chunzhen, et al.
Publicado: (2023)

Combination of Immunotherapy and Radiotherapy for Recurrent Malignant Gliomas: Results From a Prospective Study
por: Jiang, Haihui, et al.
Publicado: (2021)

SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma
por: Xu, Houshi, et al.
Publicado: (2022)

Signaling in Effector Lymphocytes: Insights toward Safer Immunotherapy
por: Rajasekaran, Kamalakannan, et al.
Publicado: (2016)

T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
por: Sim, Malcolm J. W., et al.
Publicado: (2022)

A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer
por: Ding, Ke, et al.
Publicado: (2022)

Two machine learning methods identify a metastasis-related prognostic model that predicts overall survival in medulloblastoma patients
por: Chen, Kui, et al.
Publicado: (2020)

The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients
por: Arnaud, Marion, et al.
Publicado: (2021)

Immunotherapy: A promising novel endometriosis therapy
por: Li, Wenshu, et al.
Publicado: (2023)

Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy
por: Lin, Chao, et al.
Publicado: (2023)

GPX8 regulates pan-apoptosis in gliomas to promote microglial migration and mediate immunotherapy responses
por: Chen, Zigui, et al.
Publicado: (2023)

Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions?
por: Zhu, Jiahao, et al.
Publicado: (2023)

Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma
por: Zhao, Ming, et al.
Publicado: (2023)

Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
por: Chen, Hu, et al.
Publicado: (2022)

Case Report: Overcoming challenges in pancreatic cancer with liver metastases: a personalized therapeutic odyssey of TACE, ablation, and immunotherapy
por: Zhu, Ying, et al.
Publicado: (2023)

Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside
por: Shamshiripour, Parisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5j8nvadic7ki76g0egoegkki7a